Stock Symbol IBB Share Price and Performance

The IBB share price is listed on the NASDAQ stock exchange.

The IBB ETF tracks the Nasdaq Biotechnology Index, which includes 251 biotech stocks.

The IBB share price can fluctuate significantly due to the high volatility of the biotech sector.

As of the latest available data, the IBB share price has consistently outperformed the broader market, with a 5-year annualized return of 22.1%.

IBB is a popular exchange-traded fund (ETF) that tracks the S&P 500 Index, which is a benchmark of the US stock market.

The S&P 500 Index is made up of 500 of the largest publicly traded companies in the US, covering a wide range of industries.

These companies are selected based on market capitalization, liquidity, and other criteria.

IBB is designed to provide exposure to the biotechnology sector, which is a subset of the broader US stock market.

The fund holds a diversified portfolio of biotech stocks, with a focus on large-cap and mid-cap companies.

This allows investors to gain broad exposure to the biotech sector with a single investment.

A different take: Us Cellular Ticker Symbol

To invest in IBB, you can open an account with a brokerage firm that offers access to the iShares Nasdaq Biotechnology ETF. This will provide you with the necessary tools and information to facilitate your investment.

Investors can gain exposure to a diversified portfolio of biotechnology and pharmaceutical companies by investing in IBB, which tracks the Nasdaq Biotechnology Index. This index comprises companies listed on the Nasdaq Stock Market, including both large and small-cap stocks.

It's essential to conduct thorough research and consider your investment goals and risk tolerance before making any investment decisions in IBB. Consulting with a qualified financial advisor is also advisable to ensure your investment choices align with your financial objectives.

Take a look at this: Brighthouse Financial Ticker Symbol

Investing in IBB provides exposure to a diversified portfolio of biotechnology companies, enabling investors to participate in the growth potential of this dynamic sector.

IBB tracks the performance of the rapidly advancing biotechnological sector, which is urgently needed to challenge serious ailments.

Investing in IBB allows for intraday trading, providing liquidity and flexibility for investors who wish to buy or sell shares throughout the trading day.

This can be especially beneficial for investors who want to react quickly to market changes or adjust their portfolio as needed.

Being an ETF, IBB typically has lower expense ratios compared to actively managed mutual funds, making it a cost-effective investment option.

For another approach, see: Stock Symbol B

To invest in IBB, you can open an account with a brokerage firm that offers access to the iShares Nasdaq Biotechnology ETF. This will give you the tools and information you need to facilitate your investment.

It's essential to conduct thorough research before making any investment decisions, considering your investment goals and risk tolerance. Consulting with a qualified financial advisor is also advisable to ensure your investment choices align with your financial objectives.

You can invest in IBB through various brokerage platforms, making it a convenient option for investors.

The IBB share price has seen some notable fluctuations in recent years. The starting price for this year (2025) was $132.06.

The highest price reached in 2025 was $142.79, while the lowest was $130.82. This resulted in a final price of $138.74, with an average daily volume of 370,541.

IBB's performance in 2025 was a 7.02% increase from the starting price. Here's a brief summary of the IBB share price performance:

IBB's share price has shown some variation in recent years. In 2025, the starting price was $132.06, with a highest price of $142.79 and a lowest price of $130.82.

The daily average volume in 2025 was 370,541 shares. IBB's movement in 2025 was a 7.02% increase, or 5.32% when considering the starting price.

In contrast, last year's average daily volume was significantly higher, at 487,078 shares. Despite this, the share price still decreased by 5.39% (-3.93% from the starting price).

Here's a summary of IBB's share price performance in 2025 and 2024:

This financial year, IBB's share price has seen a 2.06% increase (1.50% from the starting price), with a daily average volume of 386,863 shares.

Discover more: History of Stock Price Symbol Svm

The IBB share price has experienced some significant fluctuations over the past few months.

The lowest opening price in the given period was $111.00 on 9 April 2020.

On 29 April 2020, the share price dropped by 3.93%, closing at $124.81.

The highest daily movement was a 3.54% increase on 5 May 2020.

Here's a breakdown of the share price movements in the given period:

The biotech sector is showing signs of life, with shares of biotech companies doubling the gains of the broad market over the past few months.

The iShares Biotechnology ETF (IBB) tracks the performance of the rapidly advancing biotechnological sector, which is in high demand for advanced medical innovations.

Biotech stocks are rallying due to the prospect of lower interest rates, which could benefit investors with a stake in the sector.

The biotech sector experienced an optimistic bullish cycle in 2020-2021, leading to outperformance of the Biotech index.

However, the cycle of interest rate increases since 2022 has caused a dip in the sector, making it an attractive opportunity for investors to get back in.

The IBB ETF could be a good option for investors looking to tap into the biotech sector's potential, with its industry focus and track record of outperformance.

Jared Ablass, Vice President of Portfolio Research at TD Asset Management, believes that the biotech sector could benefit once rates start to come down, making it a potentially lucrative investment opportunity.

The biotech sector's upside potential is being debated by experts, with some arguing that it's still a good time to invest, while others are more cautious.

The biotech sector is expected to benefit once interest rates start to come down. This could lead to a recovery in biotech stocks.

Jared Ablass, Vice President of Portfolio Research at TD Asset Management, thinks the sector could be due for a bounce. He's not alone in this assessment.

Beaten down biotech stocks may be ready for a recovery, according to Ablass.

The IBB share price history shows a volatile ride in May 2020, with a high of $129.11 on the 9th and a low of $126.32 on the 7th.

The daily movement in May 2020 varied from -1.17% on the 8th to 2.93% on the 5th.

Looking at the data, it's clear that the IBB share price had significant fluctuations in May 2020, with some days showing large gains and others showing significant losses.

IBB's valuation is stretched at nearly 20x earnings, which is a historically pricey level.

The fund has underperformed the S&P 500, which is up 21%, despite a 7% YTD gain.

Its technical situation is mixed, offering no clear direction for investors.

Despite the stretched valuation, IBB remains a hold for now, pending further market developments.

The biotech sector has experienced a cycle of interest rate increases since 2022, which has caused a downturn in the industry. This has led to beaten down biotech stocks.

The biotech sector has outperformed the Biotech index in the past, as seen in the 2020-2021 optimistic bullish cycle. This shows promise for the industry's potential.

Investors who focus on the rapidly advancing biotechnological sector, such as those who track the IBB ETF, may benefit from the sector's growth.

The IBB ETF is a popular investment option for those looking to tap into the biotech sector.

It's listed on the NASDAQ exchange under the ticker symbol IBB.

The IBB ETF tracks the NASDAQ Biotechnology Index, which includes companies that are engaged in medical research and development.

This index is calculated by taking the market value of each company in the index, adjusted for the number of shares outstanding.

The IBB ETF has a relatively low expense ratio of 0.47%, making it a cost-effective option for investors.

It's worth noting that the IBB ETF has historically been a volatile investment, with price swings that can be significant.